VAN VOORHEES SETH 4
4 · PDS Biotechnology Corp · Filed Jan 6, 2021
Insider Transaction Report
Form 4
VAN VOORHEES SETH
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-04+202,800→ 202,800 totalExercise: $2.28Exp: 2031-01-04→ Common Stock (202,800 underlying)
Footnotes (1)
- [F1]The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 1, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.